Zobrazeno 1 - 10
of 603
pro vyhledávání: '"Basil S, Lewis"'
Autor:
Massimo Imazio, Allan L. Klein, Antonio Brucato, Antonio Abbate, Michael Arad, Paul C. Cremer, Antonella Insalaco, Martin M. LeWinter, Basil S. Lewis, David Lin, Sushil A. Luis, Stephen J. Nicholls, Paul Sutej, Yishay Wasserstrum, JoAnn Clair, Indra Agarwal, Sheldon Wang, John F. Paolini
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 6 (2024)
Background Rilonacept, a once‐weekly interleukin‐1 alpha and beta cytokine trap, reduced pericarditis recurrence in the phase 3 study, RHAPSODY (Rilonacept Inhibition of Interleukin‐1 Alpha and Beta for Recurrent Pericarditis: A Pivotal Symptom
Externí odkaz:
https://doaj.org/article/5b697727911f4cb89e0bb7e5b20b9221
Autor:
Antonio Brucato, Alistair Wheeler, Sushil Allen Luis, Antonio Abbate, Paul C Cremer, Liangxing Zou, Antonella Insalaco, Martin Lewinter, Basil S Lewis, David Lin, Stephen Nicholls, Massimo Pancrazi, Allan L Klein, Massimo Imazio, John F Paolini
Publikováno v:
Heart. 109:297-304
ObjectivePolypharmacy management of recurrent pericarditis (RP) often involves long-term therapies, often with negative effects. Slow tapering of oral therapies is often required to avoid recurrence. A post hoc analysis of the phase III trial Rilonac
Autor:
Paul C Cremer, David Lin, Sushil A Luis, John Petersen, Antonio Abbate, Christine L Jellis, Debbie Kwon, Antonio Brucato, Fang Fang, Antonella Insalaco, Martin LeWinter, Basil S Lewis, Liangxing Zou, Stephen J Nicholls, Allan L Klein, Massimo Imazio, John F Paolini
Publikováno v:
European Heart Journal - Imaging Methods and Practice.
Aims In this protocol-predefined sub-study of the RHAPSODY trial, the primary aim was to assess whether pericardial late gadolinium enhancement (LGE) was associated with time to pericarditis recurrence. Methods and Results RHAPSODY was a Phase 3 doub
Autor:
Juan Tamargo, Juan Carlos Kaski, Takeshi Kimura, Jack Charles Barton, Ko Yamamoto, Maki Komiyama, Heinz Drexel, Basil S Lewis, Stefan Agewall, Koji Hasegawa
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 8:738-751
Awareness of racial/ethnic disparities represents a key challenge for healthcare systems that attempt to provide effective healthcare and to reduce existing inequalities in the use of and adherence to guideline-recommended cardiovascular drugs to imp
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
Autor:
Clara, Saldarriaga, Dan, Atar, Amanda, Stebbins, Basil S, Lewis, Imran Zainal, Abidin, Robert O, Blaustein, Javed, Butler, Justin A, Ezekowitz, Adrian F, Hernandez, Carolyn S P, Lam, Christopher M, O'Connor, Burkert, Pieske, Piotr, Ponikowski, Lothar, Roessig, Adriaan A, Voors, Kevin J, Anstrom, Paul W, Armstrong
Publikováno v:
European Journal of Heart Failure, 24(5), 782-790. Wiley
Aims: Coronary artery disease (CAD) portends worse outcomes in heart failure (HF). We aimed to characterize patients with CAD and worsening HF with reduced ejection fraction (HFrEF) and evaluate post hoc whether vericiguat treatment effect varied acc
Autor:
Francesco Franchi, Stefan K. James, Tatevik Ghukasyan Lakic, Andrzej J. Budaj, Jan H. Cornel, Hugo A. Katus, Matyas Keltai, Frederic Kontny, Basil S. Lewis, Robert F. Storey, Anders Himmelmann, Lars Wallentin, Dominick J. Angiolillo
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 6 (2019)
Background There are limited data on how the combination of diabetes mellitus (DM) and chronic kidney disease (CKD) affects cardiovascular outcomes as well as response to different P2Y12 receptor antagonists, which represented the aim of the present
Externí odkaz:
https://doaj.org/article/34e8a26bf5ea40d39da99b368224987f
Autor:
John F Paolini, Fang Fang, Liangxing Zou, Manoj Samant, Yishay Wasserstrum, Paul Sutej, Stephen Nicholls, Allen Luis, David Lin, Basil S Lewis, Martin LeWinter, Antonella Insalaco, Eliyazar Gaddam, Paul Cremer, Antonio Brucato, Michael Arad, Antonio Abbate, Allen Klein, Massimo Imazio, Corina Grancorvitz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f318cc521743e425263959acc60ba9c4
https://doi.org/10.26226/m.6406112d2141dd8e29d4cb63
https://doi.org/10.26226/m.6406112d2141dd8e29d4cb63
Autor:
Irina Chazova, Salim Yusuf, Eva Lonn, Jackie Bosch, Gilles R. Dagenais, Alvaro Avezum, Claes Held, Lawrence A. Leiter, Khalid Yusoff, Robert G. Hart, Prem Pais, Patricio Lopez-Jaramillo, Karen Sliwa, Ron J.G. Peters, Basil S. Lewis, Peggy Gao, Kamlesh Khunti, William D. Toff, Christopher M. Reid, Jun Zhu
Publikováno v:
Repositorio Universidad de Santander
Universidad de Santander
instacron:Universidad de Santander
Stroke, 52(8), 2494-2501. Lippincott Williams and Wilkins
Universidad de Santander
instacron:Universidad de Santander
Stroke, 52(8), 2494-2501. Lippincott Williams and Wilkins
Digital
Background and Purpose: The HOPE-3 trial (Heart Outcomes Prevention Evaluation–3) found that antihypertensive therapy combined with a statin reduced first stroke among people at intermediate cardiovascular risk. We report secondary ana
Background and Purpose: The HOPE-3 trial (Heart Outcomes Prevention Evaluation–3) found that antihypertensive therapy combined with a statin reduced first stroke among people at intermediate cardiovascular risk. We report secondary ana
Autor:
Sigrun, Halvorsen, Julinda, Mehilli, Salvatore, Cassese, Trygve S, Hall, Magdy, Abdelhamid, Emanuele, Barbato, Stefan, De Hert, Ingrid, de Laval, Tobias, Geisler, Lynne, Hinterbuchner, Borja, Ibanez, Radosław, Lenarczyk, Ulrich R, Mansmann, Paul, McGreavy, Christian, Mueller, Claudio, Muneretto, Alexander, Niessner, Tatjana S, Potpara, Arsen, Ristić, L Elif, Sade, Henrik, Schirmer, Stefanie, Schüpke, Henrik, Sillesen, Helge, Skulstad, Lucia, Torracca, Oktay, Tutarel, Peter, Van Der Meer, Wojtek, Wojakowski, Kai, Zacharowski, Juhani, Knuuti, Steen Dalby, Kristensen, Victor, Aboyans, Ingo, Ahrens, Sotiris, Antoniou, Riccardo, Asteggiano, Dan, Atar, Andreas, Baumbach, Helmut, Baumgartner, Michael, Böhm, Michael A, Borger, Hector, Bueno, Jelena, Čelutkienė, Alaide, Chieffo, Maya, Cikes, Harald, Darius, Victoria, Delgado, Philip J, Devereaux, David, Duncker, Volkmar, Falk, Laurent, Fauchier, Gilbert, Habib, David, Hasdai, Kurt, Huber, Bernard, Iung, Tiny, Jaarsma, Aleksandra, Konradi, Konstantinos C, Koskinas, Dipak, Kotecha, Ulf, Landmesser, Basil S, Lewis, Ales, Linhart, Maja Lisa, Løchen, Michael, Maeng, Stéphane, Manzo-Silberman, Richard, Mindham, Lis, Neubeck, Jens Cosedis, Nielsen, Steffen E, Petersen, Eva, Prescott, Amina, Rakisheva, Antti, Saraste, Dirk, Sibbing, Jolanta, Siller-Matula, Marta, Sitges, Ivan, Stankovic, Rob F, Storey, Jurrien, Ten Berg, Matthias, Thielmann, Rhian M, Touyz
Publikováno v:
Halvorsen, S, Mehilli, J, Cassese, S, Hall, T S, Abdelhamid, M, Barbato, E, De Hert, S, de Laval, I, Geisler, T, Hinterbuchner, L, Ibanez, B, Lenarczyk, R, Mansmann, U R, McGreavy, P, Mueller, C, Muneretto, C, Niessner, A, Potpara, T S, Ristić, A, Sade, L E, Schirmer, H, Schüpke, S, Sillesen, H, Skulstad, H, Torracca, L, Tutarel, O, Van Der Meer, P, Wojakowski, W, Zacharowski, K, Knuuti, J, Kristensen, S D, Aboyans, V, Ahrens, I, Antoniou, S, Asteggiano, R, Atar, D, Baumbach, A, Baumgartner, H, Böhm, M, Borger, M A, Bueno, H, Čelutkienė, J, Chieffo, A, Cikes, M, Darius, H, Delgado, V, Devereaux, P J, Maeng, M, Nielsen, J C, Petersen, S E & ESC Scientific Document Group 2022, ' 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery ', European Heart Journal, vol. 43, no. 39, pp. 3826-3924 . https://doi.org/10.1093/eurheartj/ehac270
Sí
Autor:
Eugenio Stabile, Sebastian Debus, Lucia Mazzolai, Oliver Schlager, Jean-Philippe Collet, Christine Espinola-Klein, Heinz Drexel, Basil S. Lewis, Marco Roffi, Marco De Carlo, Rupert Bauersachs, Henrik Sillesen, Victor Aboyans, José F. Rodríguez Palomares, Marianne Brodmann, Dirk Sibbing
Publikováno v:
European Heart Journal. 42:4013-4024
The aim of this collaborative document is to provide an update for clinicians on best antithrombotic strategies in patients with aortic and/or peripheral arterial diseases. Antithrombotic therapy is a pillar of optimal medical treatment for these pat